CLINICAL_TRIALS
trial_result
· 2022-10-13
Clinical Trial Update: Efficacy of Pilocarpine 1% in Presbyopia [Phase 3]
Summary
Phase 3 trial update on pilocarpine 1% for presbyopia, with mention of presbyopia and pseudophakia as conditions.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Isfahan University of Medical Sciences | Conditions: Presbyopia, Pseudophakia | Phase 3 | Status: UNKNOWN